Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Plus Therapeutics Inc. | 0.759% | 0.759% | -14.209% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Plus Therapeutics Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Plus Therapeutics Inc.
Buy beendet